Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer?
- PMID: 18165631
- DOI: 10.1200/JCO.2007.14.0244
Is It time to stratify for BRCA mutation status in therapeutic trials in ovarian cancer?
Comment on
-
Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.J Clin Oncol. 2008 Jan 1;26(1):20-5. doi: 10.1200/JCO.2007.11.6905. J Clin Oncol. 2008. PMID: 18165636
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical